Aclaris Therapeutics News - ACRS

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Aclaris Therapeutics Inc ACRS NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.135 -9.51% 1.285 1.45 1.2573 1.39 1.42 14:24:16
more quote information »

Recent News

Date Time Source Heading
9/23/20194:48IHNWFeaturedCannabix Technologies Expands Marijuana Breathalyzer Portfolio with Licensing of UBC Technology for Workplace and Parental Use
9/17/201907:00GLOBEAclaris Therapeutics to Hold R&D Day
9/16/201916:15GLOBEAclaris Therapeutics’ A-101 45% Topical Solution Meets..
9/09/201907:31EDGARCurrent Report Filing (8-k)
9/05/201908:46EDGARCurrent Report Filing (8-k)
9/05/201908:30GLOBEAclaris Therapeutics Announces New Strategic Direction
8/29/201916:23EDGARStatement of Ownership (sc 13g)
8/01/201907:00GLOBEAclaris Therapeutics to Announce Second Quarter 2019..
7/31/201907:18EDGARAmended Statement of Ownership (sc 13g/a)
7/30/201916:16EDGARCurrent Report Filing (8-k)
7/30/201916:01GLOBEAclaris Therapeutics Announces Phase 2 Clinical Trial of..
7/29/201916:34EDGARStatement of Ownership (sc 13g)
7/09/201917:11EDGARStatement of Ownership (sc 13g)
7/09/201907:00GLOBEAclaris Therapeutics Announces Issuance of Additional Orange..
7/03/201916:48EDGARStatement of Changes in Beneficial Ownership (4)
7/03/201916:47EDGARInitial Statement of Beneficial Ownership (3)
7/03/201916:45EDGARStatement of Changes in Beneficial Ownership (4)
7/03/201916:16EDGARCurrent Report Filing (8-k)
7/03/201916:01GLOBEAclaris Therapeutics Announces Appointment of Maxine Gowen..
7/01/201917:03EDGARStatement of Changes in Beneficial Ownership (4)
6/26/201917:53EDGARStatement of Changes in Beneficial Ownership (4)
6/26/201916:01GLOBEAclaris Therapeutics Announces Phase 2 Clinical Trial of..
6/25/201918:32EDGARStatement of Changes in Beneficial Ownership (4)
6/17/201906:16EDGARCurrent Report Filing (8-k)
6/17/201906:00GLOBEAclaris Therapeutics Announces Positive 6-Month Results from..
6/14/201916:01GLOBEAclaris Therapeutics to Present at the 2019 JMP Securities..
6/10/201917:48EDGARStatement of Changes in Beneficial Ownership (4)
6/10/201916:57EDGARStatement of Changes in Beneficial Ownership (4)
6/10/201916:53EDGARStatement of Changes in Beneficial Ownership (4)
6/10/201916:51EDGARStatement of Changes in Beneficial Ownership (4)
6/10/201916:50EDGARStatement of Changes in Beneficial Ownership (4)
6/10/201916:50EDGARStatement of Changes in Beneficial Ownership (4)
6/07/201907:01EDGARCurrent Report Filing (8-k)
6/05/201907:03EDGARCurrent Report Filing (8-k)
5/24/201907:00GLOBEAclaris Therapeutics to Present at Jefferies 2019 Global..
5/13/201917:25EDGARStatement of Changes in Beneficial Ownership (4)
5/09/201916:59EDGARConfidential Treatment Order (ct Order)
5/08/201917:05EDGARQuarterly Report (10-q)
5/08/201916:17EDGARCurrent Report Filing (8-k)
5/08/201916:01GLOBEAclaris Therapeutics Reports First Quarter 2019 Financial..
5/01/201907:00GLOBEAclaris Therapeutics to Announce First Quarter 2019..
4/25/201907:12EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/25/201907:03EDGARProxy Statement (definitive) (def 14a)
4/25/201907:00GLOBEAclaris Therapeutics Submits Investigational New Drug..
4/24/201907:00GLOBEAclaris Therapeutics Announces Issuance of a Patent Covering..
4/04/201907:08EDGARCurrent Report Filing (8-k)
3/29/201916:41EDGARSecurities Registration: Employee Benefit Plan (s-8)
3/27/201907:00GLOBEAclaris Therapeutics to Attend Upcoming Investor Conference
3/18/201908:03EDGARAnnual Report (10-k)
3/18/201907:17EDGARCurrent Report Filing (8-k)
3/18/201907:00GLOBEAclaris Therapeutics Reports Fourth Quarter and Full Year..
See more news about this stock »


Your Recent History
NASDAQ
ACRS
Aclaris Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.